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Abstract
Background: Low level connective tissue inflammation has been proposed to play a role in
thyroid associated ophthalmopathy (TAO). The aim of this study was to investigate this postulate
by a musculoskeletal approach together with biochemical parameters.
Methods: 13 patients with TAO and 16 controls were examined. Erythrocyte levels of Zn, Cu,
Ca2+, Mg, and Fe were determined. The musculoskeletal evaluation included observational data on
body posture with emphasis on the orbit-head region. The angular foot position in the frontal plane
was quantified following gait observation. The axial orientation of the legs and feet was evaluated
in an unloaded supine position. Functional propioceptive tests based on stretch stimuli were done
by using foot inversion and foot rotation.
Results: Alterations in the control group included neck tilt in 3 cases, asymmetrical foot angle
during gait in 2, and a reaction to foot inversion in 5 cases. TAO patients presented facial
asymmetry with displaced eye fissure inclination (mean 9.1°) as well as tilted head-on-neck position
(mean 5.7°). A further asymmetry feature was external rotation of the legs and feet (mean 27°).
Both foot inversion as well as foot rotation induced a condition of neuromuscular deficit. This
condition could be regulated by gentle acupressure either on the lateral abdomen or the lateral
ankle at the acupuncture points gall bladder 26 or bladder 62, respectively. In 5 patients, foot
rotation produced a phenomenon of moving toes in the contra lateral foot. In addition foot
rotation was accompanied by an audible tendon snapping. Lower erythrocyte Zn levels and altered
correlations between Ca2+, Mg, and Fe were found in TAO.
Conclusion:  This whole body observational study has revealed axial deviations and body
asymmetry as well as the phenomenon of moving toes in TAO. The most common finding was an
arch-like displacement of the body, i.e. eccentric position, with foot inversion and head tilt to the
contra lateral side and tendon snapping. We propose that eccentric muscle action over time can
be the basis for a low grade inflammatory condition. The general implications of this model and its
relations to Zn and Se will be discussed.
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Background
The pathogenesis of orbital changes seen in patients with
thyroid associated orbitopathy (TAO) has been matter of
research since decades [1,2]. One theory that has eluded
confirmation is the proposal of a low level inflammation
of the connective tissue [3-5]. The original idea put forth
in 1995 by the research group of Jack R. Wall [3] has
found limited resonance in the scientific literature (cita-
tion analysis done with SCOPUS, Elsevier B.V.). On the
other hand, the topic of low grade inflammation is found
more frequently in relation to the metabolic syndrome, to
abdominal obesity and to cardiovascular disease as well as
in relation to decreased muscle mass and elevated
cytokine levels, e.g. of IL-6 and TNF [6-9]. A common
denominator found both in TAO as well as in these meta-
bolic situations is the elevation of cytokines [10-13]. It is
interesting to emphasize, that effective treatment of the
thyroid condition related to TAO, i.e. hyperthyroidism,
does not lead to a normalization of IL-6 levels in these
patients [11] which suggests that IL-6 might not originate
from the thyroid [14]. On the other hand, physiology
research has demonstrated that muscle tissue can indeed
produce IL-6 and TNF [15]. In spite of this fact, the role of
peripheral skeletal muscle function has been seldom eval-
uated in TAO. None the less muscular changes have been
quantified in thyroid diseases showing a situation of
diminished strength [16-18]. Therapeutical conse-
quences, however, have not been derived from these
dynamometric findings.
Elevation of glycosaminoglycans (GAGs) has also been
described to occur in TAO [19,20], however the mecha-
nisms linking GAGs to inflammation are intricate [21]
and elevated GAGs can be found in patients with other
autoimmune diseases [22]. In cases of recurrent of eye dis-
ease levels of GAGs can again be elevated [23]. A recent
publication on TAO concluded that "the elevations in uri-
nary GAGs in these patients appear to reflect widespread
stimulation of fibroblast metabolic processes, as might
occur in the setting of systemic connective tissue inflam-
mation" [24]. Mechanisms leading to GAGs elevation in
relation to connective tissue can be the scarring of fasciae
[25] as well as endoplasmatic reticulum (ER) stress [26].
GAGs are also related to the extra cellular superoxide dis-
mutase system (EC-SOD) [27]. SOD has been found to be
elevated in GD, and remains so even after an euthyroid
state has been achieved [28].
Due to the involvement of extra ocular muscles (EOM) in
TAO, investigators have also studied the role of these tis-
sues as a potential antigenic target. Based on serological
methods, putative muscle antigens have been identified in
EOM as well as in peripheral muscle tissue [29,30]. On
clinical grounds, Graves' disease can present features such
as myalgia, swelling of the calves and fasciitis [31]. Symp-
tomatology of amyotrophic lateral sclerosis has also been
reported in association with thyroid disease [32-34]. The
evaluation of muscle strength in hyperthyroid patients
has revealed a situation of reduced strength which can be
regained after therapy [16,18]. In 1977 Delporte et al.
found an association with musculoskeletal components
such as with polymyositis [35,36]. In another study an
eosinophilic fasciitis was found [37]. In 1977 one report
described manifestations of muscular and neurological
origin in hyperthyroidism. The authors called the situa-
tion hyperthyroid myopathy, a condition which was not
necessarily proportional to the hyperthyroid state, and
proposed also a polysystemic nature of Grave's disease
[38]. Finally, motor neuron alterations have also been
described in connection with hyperthyroidism [34,39].
Two recent findings clearly emphasize the relation of TAO
to musculoskeletal structures. In the first place antibodies
directed against a muscle antigen which is involved in
Ca2+ release, i.e. myocardial calsequestrin, have also been
described [40]. Ca2+ release is an immediate regulator of
muscle contraction [41-43]. In the second place, antibod-
ies directed against collagen type XIII have also been
found [44]. Collagen type XIII is found at the myotendi-
nous junctions [45].
Besides these clinical and serological aspects, imaging
methods have also provided hints regarding the involve-
ment of musculoskeletal structures. Recently it has been
shown that muscles of patients with Graves' disease
present increased peripheral glucose utilization, i.e. 18F-
fluorodeoxyglucose uptake [46]. Increased peripheral glu-
cose metabolism can either signalize inflammatory
changes [47] or increased tissue metabolism such as in
oncological conditions [48]. Indirect evidence on the
presence of inflammation in muscles of TAO patients, e.g.
neck muscles and shank, can be seen through the use of
radioactive labeled octreotide, a somatostatin analog
[49,50]. Furthermore it should be kept in mind that pos-
ture – a neuronal and musculoskeletal function – is inti-
mately related to gaze [51,52], and gaze is altered in TAO.
Again, these lines of evidence suggest an interaction with
the musculoskeletal system in TAO. One possible expla-
nation for the scarcity of clinical evaluations in this direc-
tion is the lack of sufficient clinical expertise in the field of
musculoskeletal diseases [53,54].
Considering the compelling amount of evidence men-
tioned above it appears that both the musculoskeletal sys-
tem and the connective tissue system can be involved in
TAO. The aims of the study were to analyze and character-
ize musculoskeletal elements in TAO patients using a sim-
ple functional manual clinical examination method. The
elements in this analysis were derived from features of
biomechanical functions that relate the feet to eye func-BMC Musculoskeletal Disorders 2007, 8:17 http://www.biomedcentral.com/1471-2474/8/17
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tion [51,52,55]. The presence of potential somatic dys-
function was studied using a propioceptive stretch test
[56]. Finally erythrocyte levels of Zn and Cu, which are
closely related to the function of superoxide dismutase
(SOD) [57-59], as well as the levels of Mg and Ca2+, which
are important in muscle action, were also analyzed.
Patients and Methods
The clinical and laboratory study included 13 patients
with TAO, 12 females and 1 male, age range 10–46 years
and 16 controls, 11 females and 5 males, age range 15 to
58 years. According to the Werner classification [60], all
patients were in stages I or II. Mild signs of inflammatory
activity in the form of conjunctivitis were present in 3
cases. All patients provided written consent for participa-
tion and for their identities to be revealed. At the time of
the investigation, latent hyperthyroidism was present in 5
patients. Informed consent was provided. The investiga-
tion was carried out in accordance with the Declaration of
Helsinki. The institutional ethics committee approved the
study. The investigation was done by endocrinologists
trained also in musculoskeletal methods (Applied Kinesi-
ology) as well as in acupuncture. Additional expertise on
sports physiology and physical training was contributed
by RM (Master of Advanced Studies Health and Fitness,
University of Salzburg, Austria). Neither specialized bio-
mechanical methods nor a biomechanical research facility
were available.
The initial clinical examination started with the patient
sitting and then standing in front of the investigator. For
the observations on posture the 3D coordinates were
defined as follows: the positive x direction was the for-
ward orientation, the positive y direction was the right-
ward orientation, and the positive z direction was the
upward orientation (Figure 1). Some facial characteristics
such as the inter-pupillary angle and the head on neck ori-
entation [61] were quantitatively evaluated using digital
photographic material.
Symmetry of foot movement during gait was observed in
the frontal plane. For this the patient was asked to walk an
aisle of 10 meters length. After observing the gait pattern
the patient was asked to repeat the procedure and to stop
on command during the stance phase of the representa-
tive side. While standing the angular deviation of the foot
in relation to the straight direction of motion was meas-
ured. This procedure was adapted from the method
described by Schmid [62].
The last part of the examination was conducted with the
patient in an unloaded supine position where the orienta-
tion of the legs and of the feet was evaluated. This
unloaded supine position has been described as being
adequate for the mobilization of the stretch reflex path-
Description of the axis definitions used in the study Figure 1
Description of the axis definitions used in the study. The pos-
itive x direction was the forward orientation, the positive y 
direction was the rightward orientation, and the positive z 
direction was the upward orientationBMC Musculoskeletal Disorders 2007, 8:17 http://www.biomedcentral.com/1471-2474/8/17
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way [63] where propioceptive stimuli from both the skin
and the joint are activated [64]. The clinical testing was
done using passive inversion and active rotation of each
foot. The effect of the stretch procedures was evaluated
using standard methods of Applied Kinesiology (AK) as
described elsewhere [65,66]. In this context, the propio-
ceptive provocation can elicit a so-called therapy localiza-
tion (TL) which provokes a change in muscle tonicity as
documented by EMG analysis [67]. The change in muscle
tonicity can be evidenced by the manual examination
[68]. The response pattern can thus be reduced to binary
elements, 0 = absent, or 1 = present. The identification of
a TL site indicates a local structural change. Based on the
experience gained through the investigation and treat-
ment of the index case of this model two acupuncture
points were chosen for the correction of the TL by apply-
ing acupressure on them. The points correspond to ele-
ments of the bladder and gall bladder meridians, Bl62 or
Shen mai, and GB26 or Dai mai, respectively, which have
been recently shown to be related to tendinomuscular
structures by in-vivo MRI imaging of gold acupuncture
needles inserted at these sites (submitted to BMC in
March 2006). The examination procedure is summarized
in Table 1.
Laboratory examinations included the determination of
erythrocyte levels of Zn, Cu, Mg, Ca2+, Na, K, and Fe. The
determinations were carried out at a specialized labora-
tory (Labor Bayer, Stuttgart, Germany). In a previous
study we had demonstrated that patients with thyroid dis-
ease present lower levels of Se as compared to non-thyroid
disease controls (submitted to BMC, 2006). For this rea-
son this parameter was not evaluated again in this study.
Results
Description of the posture characteristics
The visual inspection of orbital morphometry revealed
several features of facial asymmetry. These changes
included displacements of the inclination of the eye fis-
sures and altered position of the eyes in the orbit as can be
seen in Figs. 2, 3, 4. The evaluation of photographic mate-
rial of the head revealed a head inclination in relation to
the absolute vertical line ranging from 3° to 12°, mean
5.7°. The inter pupillary inclination in relation to the
absolute horizontal line was 2° to 18°, mean 9.1°. Dur-
ing the observation of the gait pattern the controls showed
a symmetrical foot orientation pattern whereas TAO
patients did not. TAO patients presented 2 types of altera-
tion: 1) an asymmetrical step pattern with one foot ori-
ented outwards, i.e. Y+, raging from 18° to 40°, mean
27°, and 2) a swinging semi-circular step pattern (not
quantified) which is shown schematically in Figure 5. In
the unsupported supine position the foot angle orienta-
tion was asymmetrical in all TAO patients having one
dominant side, i.e. the same one having the Y+ deviation
during gait. The foot angle deviation ranged from 38° to
65°, mean 50.9°. Complex deviations of the foot orienta-
tion involving the Y+ and the Z- direction were not quan-
tified. These changes are shown schematically in Figure 6.
Description of the functional testing
Using the propioceptive stretch stimulus on the feet, i.e.
passive inversion, a TL reaction was seen in 4 of 16 con-
trols and in 11 of 13 TAO patients. Active rotation of the
feet (Figure 7) was positive in 3 of 16 controls and in 12
of 13 TAO patients. The finding of a positive TL was inde-
pendent from the measured degree of axial displacement
of the feet. Active rotation of the ankle was accompanied
by a snapping sound of the joint in all TAO patients. In
addition 5 out of 13 TAO patients presented an involun-
tary movement of the toes of the contra lateral foot being
tested during foot rotation. The TL effect of these stimuli
could be eliminated by gentle acupressure of 2 seconds
duration on the pre-selected acupuncture points. The TL
arising from passive foot inversion was neutralized in
90% of cases by the Dai mai point or Gb26 (lateral abdo-
men), while the foot rotation TL was neutralized mostly
by the Shen mai point or Bl62 (lateral ankle), even in the
cases presenting the moving toes. The correction pattern
was applicable to both controls and patients.
Table 1: Outline of the WOMED clinical examination protocol
Position Parameter Characteristics
Sitting or standing Eyes in orbit Symmetry, angular displacement
Orbit on head Symmetry, angular displacement
Head on neck Rotation, tilting
Neck on trunk Rotation, tilting, tender points
Standing Hip Medio lateral height symmetry
Unloaded supine position Leg axis Symmetrical position, axial rotation
Feet on shank Extension, inversion
Functional propioceptive Foot inversion Changes in the test muscle
test Foot rotation Moving toes phenomenonBMC Musculoskeletal Disorders 2007, 8:17 http://www.biomedcentral.com/1471-2474/8/17
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Analysis of the biochemical parameters
The biochemical parameters showed a diminution of the
erythrocyte levels of Zn (p = 0.05) and an increased Cu to
Zn ratio (p < 0.05) (Table 2). The controls showed a neg-
ative correlation between Ca2+ and Mg and a positive cor-
relation between Mg and Fe. In the TAO patients these
correlations had changed. TAO patients showed a direct
correlation between Ca2+ and Cu while Fe was negatively
correlated with Ca2+and Cu (Table 3). The negative corre-
lation between Mg and Ca2+  was not found in TAO
patients.
Discussion
Based on the close relation between vision and posture
control [51,52] we hypothesized that elements related to
biomechanical features of posture and gait could be
present in TAO patients and that such changes could be
related to a low grade systemic inflammation [3,38]. In
this study we have been able to show that TAO patients
present facial asymmetry with deviation of the inter-
pupillary axis as well as of the head-on-neck position (Fig-
ures 8, 9) together with axial rotation of the legs and feet.
Active foot rotation was found to be coupled to an altered
neurological response producing the phenomenon of
moving toes in the contra-lateral foot. Until now, moving
toes have only been described in neurological patients
[69-73]. Due to the lack of a resting phase in the contra
lateral foot, one can expect that propioceptive stimuli pro-
duce altered signals in the brain, thus affecting the areas
involved in their coordination [74,75]. This feature is new
in TAO.
In addition to the moving toes phenomenon, active foot
rotation or foot inversion were associated with an altered
TAO patient showing left rotation the orbits and head as  seen by photographic documentation taken from above Figure 4
TAO patient showing left rotation the orbits and head as 
seen by photographic documentation taken from above.
A TAO patient showing moderate changes in facial symmetry Figure 2
A TAO patient showing moderate changes in facial symme-
try. Misalignments of the eyes on the orbit and of the orbit 
on the head are noted.
A TAO patient showing complex changes of facial symmetry Figure 3
A TAO patient showing complex changes of facial symmetry. 
These include Y+ changes in the head on neck position, of 
the orbital axes as well as on the alignment of the eyes on 
the orbit.BMC Musculoskeletal Disorders 2007, 8:17 http://www.biomedcentral.com/1471-2474/8/17
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propioceptive response during manual examination
which could be compensated by using acupressure on 2
specific acupuncture points. The manual examination
procedure constitutes a simple binary evaluation
approach where either altered musculoskeletal regulation
is found or not. Based on our results we propose that TAO
patients present alterations of whole body axial changes
as shown in Figure 10. The most complex situation of
axial misalignment resembles an arch-type body posture
which we have called lateral tension. This term represents
the eccentric muscle positions of the foot and leg, as well
as that of the neck muscles due to a contra-lateral head tilt
(Figure 11). Recent publications by the group of Milias et
al. [76,77] include a photograph of normal subject that
presents the typical outward rotation of the foot as we
describe here. These studies were centered on the actions
of Se on muscle function tests and included dynamomet-
ric analysis. This postural alteration, however, was not
characterized by the authors. Literature evidence on the
potential interactions of these musculoskeletal changes
on posture is summarized in Table 4.
On the biochemical side, our study has confirmed the
finding of diminished erythrocyte Zn levels in hyperthy-
roidism [78,79]. Zinc plays an important role in the main-
tenance of multiple body functions. One general function
is that of providing site-specific antioxidative protection
together with Se [80]. In a recent study we have also dem-
onstrated that patients with thyroid disease have dimin-
ished levels of Se (submitted to BMC, 2006). We will
mention some aspects that appear relevant to TAO. Low
erythrocyte levels of Zn are characteristic of hyperthy-
roidism and not of subacute thyroiditis [81], thus suggest-
ing that different pathogenetic mechanisms are involved
in these entities. Zn availability is a key factor for the
development and function of the immune system [82-
84]. Fraker et al. have pointed out the importance of Zn
supplementation in order to overcome "the dismantling
of the immune system" [85]. Studies on TAO have seldom
considered Zn even though it is an important regulator of
retinal function [86-88]. Neuritis of the optic nerve has
also been described as being associated with low Zn levels
[89]. Smoking, which is a known risk factor for TAO
[90,91], can lead to diminished Zn levels in serum [92].
Muscle and tendon function are also related to Zn. Zn
uptake has been located to the connective tissue space of
muscle [93]. Lack of Zn could diminish collagenase activ-
ity leading to a hardening of tendon tissue resulting in the
characteristic snapping we have documented. Regarding
the other biochemical parameters, we have not found any
studies that have analyzed erythrocyte Ca2+ and Mg levels
Description of the changes in foot alignment while lying supine in an unloaded position Figure 6
Description of the changes in foot alignment while lying supine in an unloaded position. The left panel shows a symmetrical 
position. The middle panel shows a slight displacement of the Y axis. The right panel shows a more pronounced displacement 
of the foot in the Y axis corresponding to inversion.
Description of the foot orientation patterns observed during  gait Figure 5
Description of the foot orientation patterns observed during 
gait. The left panel shows a symmetrical gait. The middle 
panel shows a lateral foot deviation. The right panel signalizes 
a rotating, semicircular pattern of foot advancement.BMC Musculoskeletal Disorders 2007, 8:17 http://www.biomedcentral.com/1471-2474/8/17
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in TAO patients. Further implications of these findings
will be discussed below.
The scientific literature has abundant data on biomechan-
ical evaluations of gait and posture, but none has been
carried out in TAO patients. In the majority of studies,
normal subjects restricted through the use of a bracing
apparatus have been evaluated. Under these conditions,
the innate posture cannot be characterized. Quantitative
approaches, i.e. dynamometry, have revealed that muscle
strength is diminished in patients with hyperthyroidism.
In spite of having quantitative data on muscle strength,
these studies [16-18] have not attempted to derive correc-
tive procedures as we have done. A beneficial role of mus-
cle strength for the prevention of falls was mentioned by
Brennan [16]. We will comment on this in the outlook
section.
The description of new features of TAO patients arising
from this study is a consequence of the philosophy of our
Institution WOMED. Here we are committed to deliver an
integral approach to disease in each individual. Within
this frame we have previously described therapeutical
measures for treating periorbital edema in TAO [67] or
daily stress burden in hyperthyroidism [94]. For this rea-
son, we have chosen to call our results and observations
the WOMED concept of lateral tension. This concept
includes components of musculoskeletal function, endo-
crine function, and nutrition.
The following discussion will expand to deal with the fol-
lowing topics: 1) muscle involvement in Graves' disease
and TAO, 2) effects of eccentric muscle action on muscle
inflammation, 3) calsequestrin and the Ca2+ regulation
system, 4) involvement of the connective tissue and
superoxide dismutase (SOD), 5) propioception and bio-
mechanical implications, 6) functional imaging data in
relation to the model, and 7) summary of the WOMED
concept of lateral tension in the context of inflammation
and IL-6.
1) Muscle involvement in Graves' disease and TAO
On clinical grounds, thyroid disease can be found to be
associated with musculoskeletal components such as with
polymyositis [35,36], eosinophilic fasciitis [37], as well as
with myalgia and swelling of the calves and fasciitis [31].
Recent investigations have found an increased peripheral
glucose utilization, i.e. 18F-fluorodeoxyglucose uptake in
the muscles of patients with Graves' disease [46].
Increased peripheral glucose metabolism can signalize
inflammatory changes [47]. Finally, indirect evidence on
the presence of inflammation in muscles of TAO patients,
e.g. neck muscles [50] and shank [49] (Figure 12), can be
seen through the use of radioactive labeled octreotide, a
somatostatin analog which can depict immunological or
Table 2: Comparison of erythrocyte mineral and metal levels
Study Groups Ca Mg Zn* Cu Mg Ca ratio Cu Zn ratio**
TAO patients n 1 31 31 31 31 31 3
Mean 60,78 33,82 6,75 1,42 0,56 0,22
S.D. 3,11 2,31 1,22 0,48 0,04 0,08
min. 56,89 30,14 4,30 1,02 0,50 0,13
max. 68,65 37,29 8,57 2,82 0,62 0,40
Normal 
controls
n 1 61 61 61 61 61 6
mean 60,73 33,41 7,41 1,25 0,55 0,17
S.D. 1,83 3,01 0,46 0,32 0,06 0,04
min. 56,70 29,19 6,40 0,90 0,47 0,12
max. 64,45 38,14 8,17 1,96 0,67 0,27
* p = 0.05, ** p < 0.05
Description of the foot rotation test by which several muscle groups are activated Figure 7
Description of the foot rotation test by which several muscle groups are activated. Besides the muscle activation propioceptive 
stimuli arise from skin and tendon stretching.BMC Musculoskeletal Disorders 2007, 8:17 http://www.biomedcentral.com/1471-2474/8/17
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inflammatory sites in TAO [95]. Alterations of neck mus-
cles can be viewed as being directly related to postural
changes [96-99]. While previous investigations in TAO
have focused on the EOM, it should be recalled that there
are large differences in muscle mass between the EOM and
the limb muscles. EOM have a volume of 3–5 ml
[100,101], while the muscle mass of the legs together with
abdominal muscle can amount to 15–20 kg [102,103]. It
follows, that biochemical markers of inflammation such
as GAGs [19,20] are more likely to come from peripheral
muscles. The postural changes we describe here corre-
spond to an eccentric muscle action of peripheral muscles.
The consequences of eccentric action will be discussed in
the following section.
2) Effects of eccentric muscle action on muscle 
inflammation
Investigations from the field of sports medicine have pro-
vided an ample repertoire of evidence relating eccentric
muscle action to muscle inflammation, cell disruption
and involvement of the connective tissue [104]. Some
selected aspects include the visualization of anatomical
changes such as edema by means of MRI [105], the pres-
ence of WBC in muscle [106], the disruption of the
cytoskeleton and myofibrils [107-109], the involvement
of collagen and of collagen degrading enzymes [110,111],
the involvement of tendons [112] and fasciae [113], the
release of IL-6 [114], as well as the release of bradykinin
and of histamine through the induction of histidine
decarboxylase [115-119]. In addition to this, neuromus-
cular changes and dysfunction can appear [120-125]. The
phenomenon of moving toes might be related to this neu-
romuscular dysfunction. Finally an asymmetrical body
posture will influence the mechanics of the hips [126].
Figure 13 shows an extended description of the interac-
tions of eccentric muscle action on tissue injury and
repair.
Table 3: Correlation analysis of Zn, Ca, Mg and Cu levels
Mg Cu Zn Fe
TAO Ca r 0,239 0,641* -0,060 -0,758**
p 0,432 0,018 0,845 0,004
n 1 31 31 31 2
Mg r -0,042 0,121 0,125
p 0,892 0,693 0,699
n1 3 1 3 1 2
Cu r 0,116 -0,663*
p 0,706 0,019
n1 3 1 2
Zn r -0,165
p 0,609
n 12
Controls Ca r -0,632** 0,357 -0,085 -0,485
p 0,009 0,175 0,756 0,057
n 1 61 61 61 6
Mg r -0,349 -0,097 0,625**
p 0,186 0,721 0,010
n1 6 1 6 1 6
Cu r 0,094 -0,347
p 0,730 0,188
n1 6 1 6
Zn r -0,277
p 0,300
n 16
* The correlation is significant at a level of 0,05 (2-sided).
** The correlation is significant at a level of 0,01 (2-sided).BMC Musculoskeletal Disorders 2007, 8:17 http://www.biomedcentral.com/1471-2474/8/17
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3) Calsequestrin and the Ca2+ regulation system
In order to understand the potential impact of antibodies
directed against cardiac calsequestrin (CSQ) as shown by
Gopinath [40] were carried out a revision of basic and cur-
rent literature dealing with Ca2+ regulation. The result of
this literature analysis is summarized in Figure 14. CSQ
represents only a part of the system of Ca2+ regulation. In
addition to this it must be remembered that the slow type
CSQ is a cardiac element and not highly specific for EOM
[40]. It follows that these antibodies might be more rele-
vant to cardiac manifestations of thyroid disease. On the
other hand functional alterations of EOM do show an
involvement of CSQ [127]. Modern analytical methods
have documented the heterogeneity of anatomical and
functional elements of EOM which makes them unique.
One example involves the structural differences of the dif-
ferent layers of EOM [128]. One important functional fea-
ture of EOM is that they are to be considered as tonically
active muscles such as the diaphragm where function
integrity depends upon the sufficient availability of anti-
oxidant substances such as Se and SOD [129]. Another
important regulator of EOM function integrity can be Ca2+
[130].
We have recently shown the importance of Se in relation
to thyroid antibody levels in incipient hypothyroidism:
antibodies were present when Se levels were inadequately
low [131]. Once Se substitution has been implemented,
thyroid antibody levels will diminish. These results are
similar to those presented by Turker et al. [132]. Recently
it has also been demonstrated that thyroid disease
patients have lower Se levels as compared to controls
(Moncayo and Moncayo, submitted to BMC, 2006). It fol-
lows that antioxidative protection can be altered in TAO.
Additional interactions between Ca2+, Se, and selenopro-
teins can occur through the ryanodine receptor as shown
in Figure 14.
Interactions of Ca2+ and Zn are known to exist in relation
to calsequestrin [133]. In relation to eccentric changes due
to chronic cardiac volume overload, changes in Ca2+ and
calsequestrin can result in altered contraction responsive-
ness to Ca2+ [134]. A further relation to muscle function
Schematic summary of the WOMED concept of lateral ten- sion Figure 10
Schematic summary of the WOMED concept of lateral ten-
sion. The four panels describe the graded development of lat-
eral tension. Panel A shows the symmetrical body position. 
Panel B includes only Y+ tilting of the head. Panel C includes 
Y+ tilting, alteration of the orbits and slight eccentric posi-
tion of the leg and foot. Panel D shows the complex pattern 
with head, orbit, face and lower limb asymmetry. We pro-
pose that in this stage eccentric muscle action will induce low 
grade inflammation.
Schematic representation of the head on neck on trunk pos- tural changes showing head rotation in a Y+ direction Figure 8
Schematic representation of the head on neck on trunk pos-
tural changes showing head rotation in a Y+ direction. 
Besides this rotation, lateral head tilting can also be present.
Schematic representation of the pitch changes of the head on  neck position Figure 9
Schematic representation of the pitch changes of the head on 
neck position.BMC Musculoskeletal Disorders 2007, 8:17 http://www.biomedcentral.com/1471-2474/8/17
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can be found in the histidine-rich Ca2+-binding protein
which can also bind Zn and is localized in the sarcoplas-
mic reticulum [135]. Thus it appears that the changes in
the intracellular concentration of ions and metals might
be affecting muscular function. Some of these relations
have been described in ALS [57,58,136,137]
4) Involvement of the connective tissue and SOD
As described above an eccentric muscle action represents
a situation of tissue damage involving muscles, tendons,
fasciae and the connective tissue. Protection against these
processes can be expected to come from superoxide dis-
mutases (SOD) [138-140]. The extra-cellular SOD (EC-
SOD) has the capacity to bind several components of the
connective tissue such as heparin, collagen and GAGs
[141], some of which can be found to be altered in TAO
[27]. The maintenance of functional SOD subtypes
requires an adequate supply of Zn and Cu [142,143]. In
our patients we have not been able to measure these
parameters in muscle tissue, however erythrocyte levels
can be taken as a surrogate compartment [59]. In scoliosis
it is known that Zn levels are lower in the affected muscles
[144]. Thus, the same might happen in TAO. We can only
speculate that the functions of SOD might be influenced
by the shift of ions and metals we have found as is known
in amyotrophic lateral sclerosis (ALS). Zn deficiency can
alter the SOD so that it can be neurotoxic locally [145].
Extrapolating from experimental data neurotoxicity could
affect elements involved in inhibitory regulation of neural
function such as the spinal cord [146,147] or cerebellar
cortex [148]. In turn, cerebellar structures are involved in
muscle action and coordinated muscle action [149-151].
Our finding of moving toes in TAO patients could corre-
spond to a situation of lack of spinal cord inhibition.
5) Propioception of the lower extremity and general 
biomechanical implications
Considering that mechanical test procedures for ankle sta-
bility are liable to problems [152] we chose to use a sim-
ple manual test for the evaluation of ankle mobility based
on principles of Applied Kinesiology. Dedicated research
centers utilize electromagnetic devices for a similar pur-
pose [153]. Guralnik et al., using a small battery of func-
tional tests, have shown that lower extremity function is
an important parameter for the prediction of disability in
later years [154]. Within this field of prediction of disabil-
ity-related problems, clinical investigations should
attempt to detect alterations and implement correction
measures. Our simple manual method has the advantage
that once a TL has been found, the effectiveness of a cor-
rection step can be evaluated. In our study the use of acu-
pressure on the lateral side of the abdomen or of the ankle
was enough for reversing this propioceptive stimulus.
Based on the observations of Roll and collaborators refer-
ring to the interactions between the dynamometric map
Simulated patient photography demonstrating the lateral ten- sion concept Figure 11
Simulated patient photography demonstrating the lateral ten-
sion concept. The basic elements of the model are included.BMC Musculoskeletal Disorders 2007, 8:17 http://www.biomedcentral.com/1471-2474/8/17
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function of the feet and posture regulation [155,156] we
can corroborate this notion. Tension transmission along
the foot, ankle and lower limb to the trunk belong to our
WOMED concept of lateral tension (Figure 11). Tension
transmission is based on the principle of fascia and fascial
continuity [157]. More importantly in 1989 Roll, Vedel
and Roll described the intricate relation between the ret-
roocular muscles and posture control [55]. Lack of ankle
function in relation to posture might be an important fac-
tor in the tendency to fall which turns to be a matter of
serious concern in older patients. Analytical studies have
revealed the importance of gait variability in relation to
stride width [158]. Others have emphasized that all ankle
motions contribute to the maintenance of gait balance
[159]. Our rotational propioceptive stimulus includes all
these conditions of ankle motions. In addition, neuro-
physiological investigations on the acupuncture points of
the lateral side of the foot have shown a relation to the vis-
ual cortex [160,161] thus showing complementarity to
the data from Roll. Altogether, the foot and ankle appear
to be important determinants of gaze, posture and gait.
The area of the trunk also plays an important role in con-
trolling the direction of gait. As has been shown by
Schmid et al. angular deviations of the foot can occur
when vibrational stimuli are applied to the trunk at the
level of the erector spinae muscle [62]. Trunk movements
do not only involve the back; abdominal muscles are
involved as well [162-164]. All of these muscular ele-
ments bear resemblance to the acupuncture meridian
called girdling vessel or Dai mai vessel. Classical TCM lit-
erature attributes a holding function to this meridian. Our
own imaging investigations (submitted to BMC March
2006) have led us to identify the obliquus internus muscle
as the structure underlying the Dai mai point (Gb26) and
the tendon of the peroneus muscle at the Shen mai point
(Bl62). Punctual EMG analysis of these points during
examination of movement should be feasible in special-
ized biomechanical laboratories.
6) Scintigraphic imaging data in relation to the model
We would like to highlight the diagnostic possibilities of
Nuclear Medicine in the context of the model. Figure 15
shows the diagnostic capabilities of combined PET-CT
scanners (in this example SIEMENS, Erlangen, Germany).
The fused image, i.e. superposed PET and CT whole body
images, shows metabolic activation of the left lateral
shank while at the same time the right ankle also shows
increased metabolic activity. We interpret this image in 2
ways. In the first place it shows the anatomical localiza-
tion of the changes we describe. In the second place it
demonstrates the research capabilities of whole body PET-
CT imaging in musculoskeletal studies with emphasis put
on "whole body analysis". The image was kindly provided
by Dr. David Townsend, University of Tennessee [165].
A second interesting image is one that shows increased
metabolic activity in the lateral area of the abdomen
[166]. These areas correspond to the Dai mai acupuncture
point (see discussion in the preceding section) which is
located below the free end of the 11 th rib. In addition to
this, the morphological CT images also show the medio
lateral displacement of the body axis (Figure 16). For clin-
ical purposes, precise clinical evaluation of trunk devia-
tion can be carried out by rasterstereography [167].
Besides the examples given here, we would like to stress
the applicability of whole body 18F-Fluorodeoxyglucose
imaging as an investigational tool to characterize whole
body muscle activity in vivo [168-176] or even tendon
activity [177]. In a whole body approach both agonistic
and antagonistic muscle groups can be evaluated and a
metabolic quantification can be done.
7. The WOMED concept of lateral tension, inflammation 
and IL-6
The WOMED concept of medical care can be summarized
as an integral care of the individual. Within this concept
elements of TCM and Western medicine are intermingled.
Some of the evaluation parameters used in each patient
are posture, locomotion, structural cohesion, previous
infectious diseases, nutrition habits, nutritional status,
internal medicine evaluation, and gynecological evalua-
tion when needed. In addition to this both endocrinolog-
ical and immunological aspects are included. Examples of
this medical approach have been published [67,94,131].
Our interpretation of lateral tension involves eccentric
muscle action. Due to the contained structure of the orbit
with limited expansion, it does not appear plausible that
the initial lesion occurs here. On the other hand, due to
the frequent involvement of the ankle in daily lesions
[178-180] it seems plausible that the initial pathogenic
stimulus arises from this area. In addition to lesions of the
lower limb, postural problems are not seldom found even
in young children [181]. Therefore pre-existing postural
changes together with low grade eccentric action could
have a negative effect on the musculoskeletal system lead-
ing to a low grade inflammation which can also lead to
consumption of vital resources such as Se and Zn. Lack of
antioxidants will give way to an elevation of IL-6 [182].
The role of IL-6 in muscle metabolism has been matter of
intense investigation over the past years. IL-6 appears to
have several effects on the muscle and appears to play a
role in the control of normal muscle function [183]. Acti-
vation of muscular IL-6 release depends also on glycogen
levels [184], as well as on the interplay of Ca2+ [185].
Repetitive low force exercise can also lead to increased
interstitial concentrations of IL-6 [186]. The area sur-
rounding the Achilles tendon can be taken as an example
for changes seen in eccentric exercise and can be character-BMC Musculoskeletal Disorders 2007, 8:17 http://www.biomedcentral.com/1471-2474/8/17
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ized by means of microdialysis studies [186-188]. This
type of investigations can provide an anatomically close
view of the changes that can occur. Inflammatory reac-
tions can indeed be found by this method even when
there are no apparent changes in blood [186-188]. A
graphical summary of mechanisms of inflammation is
given in Figure 17 pointing out the relevance of Se. Fur-
ther vinculations to insulin resistance, as a part of the so-
called metabolic syndrome, are also included.
The lateral tension model bears resemblance to the bio-
mechanical five segment model of Levin et al. [189] where
the feet, the legs and the abdomen are viewed as a unit.
Our study has shown that the use of acupressure on the
lateral abdomen normalized the TL produced by the
stretch stimulus thus suggesting an important role of it for
posture. Biomechanical observations have shown that a
primary activation of these muscles occurs during gait
[190] and that these muscles influence the mechanics and
the tension of the back [191,192]. Altered foot position-
ing, as we have found here, can also be produced by mus-
cle stimulation from the back [62]. This underlines the
functional relationships of the ankle and trunk in loco-
motion [189]. The Dai mai point, located at the lateral
abdomen, can be considered to be a trigger point [193]
that represents the existing biomechanical tension arising
from eccentric exercise. Tension will lead to taut band for-
mation and this can be found by manual examination.
Conclusion
The WOMED concept of lateral tension which is centered
around the abdominal muscles might be applicable to
other conditions of musculoskeletal diseases. It is impor-
tant to point out that our proposed use of acupuncture to
treat fascial changes in the WOMED model of lateral ten-
sion coincides with the expectations from Shah et al.
[187]. They propose the used of microdialysis needles as
surrogates for acupuncture needles to treat myofascial
trigger points. By our means of manual clinical investiga-
tion, relevant myofascial trigger points can be found eas-
ily. For analytical scientific research procedures such as
dynamometry, body surface scanning, and in-vivo micro-
dialysis will provide figures and numbers related to our
model. It can be expected that 2D separation of serum
proteins will allow a closer insight into the changes in the
proteome in selected diseases [194]. Our clinical experi-
ence in patients with TAO, multiple sclerosis, fibromyal-
gia and similar conditions suggests that successful
treatment can rely on acupuncture techniques that aim at
correcting the integration of neurophysiological inputs.
Simple but relevant quotes
We are involved with musculoskeletal function every day
and take it for granted. For this reason every day use might
not appear to be relevant to disease in the first place. Terry
F. Davies, Editor in Chief of Thyroid, has made reference
to this situation while commenting on the pathogenesis
of TAO: "It maybe very well be true that there is nothing
new under the sun – it is just that we have either forgotten
it or never understood it" [195]. While this applies to
daily motor accomplishments, unusual musculoskeletal
exercise with repetitive eccentric muscle action can pro-
duce an acute situation similar to the one we describe. The
impressions of Lance Armstrong after the N.Y. marathon
in November 2006 illustrates this: "Even after experienc-
ing one of the hardest days of the Tour nothing has ever
left me feeling this bad," he said at a post-race news con-
ference. " [My shins] started to hurt in the second half, but
the bigger problem the last 7 or 8 miles was the tightness
in my calves and thighs. My calves really knotted up. I can
Table 4: Postural changes observed in TAO patients and implications of these changes
Basic structure Related organ Description of the alteration Axes Potential effects
Head Eyes Elevation, tilted X, Y, Z postural alignment [196,197]
Neck Rotated, tilted, extended or flexed X, Y, Z dorsal muscles [198] ocular torticolis [96,97]
Nose Tilted Y, Z Retro nasal space?
Mouth Tilted Y Jaw [199]
Face Asymmetry Head holding [200]
Neck Trunk Rotated Y Lymphatics, posture [200,201]
Trunk and abdomen Rotated Increase of the intra-
abdominal pressure
Y Foot angle [62] Pelvic girdle pain [202]
Leg Pelvis Gluteus m. Rotated Y Hip sway Transversus abdominis [190] Altered 
femoral control [203]
Ankle Shank Hip Reduced range of motion X, Y, Z Instability [204], Sway Sensory changes and 
hypermobility [205,206] Altered hip load – unload 
[126] Hip weakness [207]
Feet shank Lateral displacement Y, Z Tightness of lateral calf muscles [156]
Feet Sole Asymmetry Y Posture information [155] Influence on retroocular 
muscles [55]
Foot to head Whole body Posture asymmetry [208]BMC Musculoskeletal Disorders 2007, 8:17 http://www.biomedcentral.com/1471-2474/8/17
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barely walk right now." Figure 18 presents a graphical
summary of the model together with potential every day
stressors such as bicycle riding and running.
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Image fusion of CT and scintigraphic data showing diffuse Octreotide uptake in the lower limbs of a patient with TAO Figure 12
Image fusion of CT and scintigraphic data showing diffuse Octreotide uptake in the lower limbs of a patient with TAO. Octre-
otide uptake represents inflammatory activity. Taken from [49]. Each reconstruction plane is labeled in the upper left corner of 
the image. The right lower image is an anatomical reconstruction of the surface of the leg.BMC Musculoskeletal Disorders 2007, 8:17 http://www.biomedcentral.com/1471-2474/8/17
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Note
The WOMED concept of lateral tension Changes in mus-
cle and connective tissue due to eccentric muscle exercise
[209-212]
1 Sarcomere damage [108,213-215]
1.1 Potential bias in biopsy studies [216,217]
1.2 Weaker sarcomeres absorb more stretch [214]
1.2.1 sarcomere damage in myofibrils [107,109]
1.2.2 Desmin, titin, junctin [218]
force reduction [219,220]
stiffness [221]
increased levels of CK and LDH. Increased hydroypro-
line and hydroxylysine excretion [222]
muscle fragments and myosin [108,223]
Desmin, titin, junctin [109]
Troponin I [224]
Graphical summary of relevant scientific data related to the effects of eccentric muscle action Figure 13
Graphical summary of relevant scientific data related to the effects of eccentric muscle action. The images recollect physiolog-
ical data as well as nutritional and endocrine aspects. Emphasis is put on the roles of Zn and Se.BMC Musculoskeletal Disorders 2007, 8:17 http://www.biomedcentral.com/1471-2474/8/17
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1.2.3 progressive weakness and low muscle tone
[220,225]
1.2.4 over stretched sarcomeres [226,227]
disruption of EC [228,229]
increased number of sarcomeres [230]
failure to reconnect and shortening [231]
swelling [105,223,225,232]
stimulation of ankyrin [233]
connection of ankyrin to obscurin and titin [234,235]
ECM disruption[236]
Siehe auch: Connective tissue[42]
1.2.5 active contractile fibers turn into passive elastic tis-
sue
altered nociceptor sensitation and neurological acco-
modation
passive tension [237] and mechanical laxity [180]
involvement of tendons [112,238,239]
decreased ankle ROM [76]
fascial compartments [240]
1.3 Inflammation mediators [104,241]
1.3.1 IL-6, TNF [15,117,242]
1.3.2 IL-6 polymorphism and Increased inflammatory
response by -174 G>C [243]
Graphical summary of relevant scientific data related to Ca regulation Figure 14
Graphical summary of relevant scientific data related to Ca regulation. Ca regulation has been suggested to be important in 
TAO. This assumption is based on the finding of antibodies directed against calsequestrin [40,370]. Interactions with Zn and Se 
are included.BMC Musculoskeletal Disorders 2007, 8:17 http://www.biomedcentral.com/1471-2474/8/17
Page 16 of 30
(page number not for citation purposes)
1.3.3 IL-6 regulates the Zn transporter Zip-14 [244]
pro-inflammatory cytokines
1.3.4 Influence of aging [245]
1.3.5 granulocytes and neutrophils [106,246]
1.3.6 c-Fos and lipocortin II [215]
1.3.7 induction of histidine decarboxylase [118,119]
1.3.8 increased levels of bradykinin [116]
1.3.9 interactions in nociception [247]
1.3.10 ubiquitin proteosome proteolysis [246]
1.3.11 role of gender [248]
1.3.12 Antioxidants diminish cytokine response [249]
1.3.13 activation of the c-Jun NH(2)-terminal kinase
(JNK) [250]
1.4 Elements of Ca regulation [251,252]and EC coupling
[253]
1.4.1 reduced Ca levels [253,254]
1.4.2 ryanodine receptor, calmodulin [251,255]
1.4.3 calsequestrin [42,133,253]
1.4.4 parvalbumin (in motoneuron) [137]
excitoxicity [256]
Metabolic imaging using 18F-Fluorodeoxyglucose (18F-FDG)  showing metabolic activity in the lateral abdomen (dark  areas) Figure 16
Metabolic imaging using 18F-Fluorodeoxyglucose (18F-FDG) 
showing metabolic activity in the lateral abdomen (dark 
areas). These areas are located around the Dai mai point 
which has been evaluated in our study. The accompanying 
CT images shows a clear deviation of the body axis at the 
level of the trunk. The images are reproduced with kind per-
mission of the Society of Nuclear Medicine [166].
Metabolic imaging using whole body 18F-Fluorodeoxyglucose  PET and CT Figure 15
Metabolic imaging using whole body 18F-Fluorodeoxyglucose 
PET and CT. Note the metabolic activity on the lateral side 
of the left lower limb as well as on the right ankle. The area 
around the ankle corresponds to the Shen mai acupuncture 
point which has been evaluated in our study. Shank muscles 
are commonly more active in locomotion. The image was 
provided courteously by Dr David Townsend, University of 
Tennessee [165].BMC Musculoskeletal Disorders 2007, 8:17 http://www.biomedcentral.com/1471-2474/8/17
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1.4.5 Ca, SERCA [254]
SERCA 1 in fast twitch fibers [251]
SERCA 2 in slow twitch fibers [251]
SERCA in EOM [257]
Relation to thyroid hormones [258,259]
Relation to extraocular muscles [257]
1.4.6 Triadin [253]
1.4.7 Junctin in myocyte [218]
1.5 Muscle repair processes
1.5.1 mTOR [260,261]
1.5.2 Satellite cells [262-264]
1.5.3 Zn, MMP and remodelling [265,266]
1.5.4 Telomerase in fatigue associated myopathy [267]
2 Connective tissue [236]
2.1 mechanosensory effects [268,269]
2.2 mechanosensation of the skin [270]
2.3 Structural changes
2.3.1 SOD changes ? [271]
2.3.2 release of glycosaminoglycans ? [27]
2.3.3 GAGs in ER [26]
2.3.4 Scarred fascia and GAGs [25]
2.4 interactions with collagen
2.4.1 collagen degrading enzymes: TIMP-1, TIMP2-
MMP2, MMP-9 [110,265,272,273]
2.4.2 procollagen processing [111]
2.5 Potential interaction with fasciae [240]
2.6 increased levels of bradykinin and adenosine [115,116]
3 Neuromuscular dysfunction [120,122,124,125]
3.1 Reduced reflex sensitivity [121]
3.2 Alpha motoneuron pool recruitment [122]
3.3 Alteration in sense of effort and motor command [123]
3.4 C-FOS expression in anterior pretectal nucleus in relation
to pain [274]
3.5 C-FOS in the dorsal horn due to compression [275]
3.6 sensory control and inflammatory mediators [247]
Graphical summary of scientific data related to inflammation as it can be applied in TAO and in metabolic disorders including  insulin resistance Figure 17
Graphical summary of scientific data related to inflammation as it can be applied in TAO and in metabolic disorders including 
insulin resistance. Interactions with IL-6 and Se are depicted.BMC Musculoskeletal Disorders 2007, 8:17 http://www.biomedcentral.com/1471-2474/8/17
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3.7 Neuromuscular activity modulates myonuclear domain size
[263]
3.8 Nervous system strategies [276]
3.8.1 Eccentric exercise and brain activation
3.8.2 Brain activation and ECC
3.8.3 Brain control of coordinated movements
4 Nutritional and endocrine factors
4.1 Mg and Ca
4.1.1 Decrease of the ion dependent binding of spin
labeled ATP [277]
Abbridged representation of the WOMED concept of lateral tension in relation to inflammation and daily low level stressors Figure 18
Abbridged representation of the WOMED concept of lateral tension in relation to inflammation and daily low level stressors. 
Further details can be extracted from figures 13, 14 and 17.BMC Musculoskeletal Disorders 2007, 8:17 http://www.biomedcentral.com/1471-2474/8/17
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4.2 Selenium [55]
4.2.1 Decreased levels in thyroid disease (Moncayo 2006)
4.2.2 Se in the pituitary [278]
4.2.3 Se and muscle [279]
4.2.4 Se and heart [280]
4.2.5 Se, mTOR and muscle hypertrophy [281]
4.3 Selenoproteins
4.3.1 Selenoprotein S influences inflammatory response
[282]
4.3.2 Selenoprotein K – a cardiac antioxidant [280]
4.3.3 Selenoprotein N – muscular dystrophies [283]
4.3.4 Selenoprotein N1 – insulin resistance [284]
4.3.5 Selenoprotein W and muscle growth [285]
4.4 Zinc
4.4.1 Calsequestrin [133]
4.4.2 Bradykinin [286]
4.4.3 Zn and Cu and Ca binding proteins [287]
4.4.4 Influence on TRH processing [288]
4.4.5 Zn and MMP in muscle repair [265]
4.4.6 Zn and mTOR [289]
4.4.7 Synaptic activity [290]
4.4.8 Inhibitory activity in the spinal cord [146]
4.4.9 Sciatic nerve lesions and Zn transport [291]
4.5 Se and Zn
4.5.1 Zn-Se nanocrystals in the pituitary [292]
4.6 Vitamin E [293]
4.7 Thyroid hormones [294,295]
4.7.1 Regulation of muscle gene expression [294]
4.7.2 SERCA [259,296]
4.7.3 SERCA and thermogenesis [258]
4.7.4 Satellite cells [297]
4.7.5 Change in Myosin and SERCA isoforms [295]
4.7.6 Force reduction [298]
4.7.7 Changes in Ca uptake [299]
4.8 Insulin resistance [300,301]
4.9 Altered glycogen accumulation [302]
5 Muscle action of extraocular muscles
5.1 Consideration of muscle volume
5.1.1 EOM [100,101]
5.1.2 Volume of limb and abdominal muscles [102,103]
5.2 Inapparent TAO [303,304]
5.3 Thyroid hormone receptors in EOM [305,306]
5.4 Satellite cells [307,308]
5.4.1 Activated satellite cells in overacting EOM [309]
5.5 Alterations in gaze [310]
5.6 SERCA in extraocular muscles[257]
5.7 Muscle overaction and Ca uptake [127]
5.8 Neck vibration in strabismus [311]associated with changes
in congruent muscle propioceptive information
5.9 Head and eye movement in MRI [312]
5.10 Influence of waist disturbance on gait [313]
5.11 Ocular motility [314]
5.12 Layer specific EOM structure [128,315-317]
6 Role of brain integration in movement coordination
6.1 Interlimb coordination [318]
6.2 Lateralization of lower limb movements [151]BMC Musculoskeletal Disorders 2007, 8:17 http://www.biomedcentral.com/1471-2474/8/17
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6.3 Coordination of ankle movements [150]
6.4 Active and passive ankle movements [319]
Regulation of Ca Release [320]
1. Ca cycling [254]
2. SERCA
2.1. SERCA 1 fast fibers
2.1.1. Sarcolipin (SLN) [321,322]
2.1.2. Brody disease [320]
2.2. SERCA 2 slow fibers
2.2.1. Phospholamban (PLB) [321,322]
3. Calsequestrin (high capacity – low affinity)
3.1. CSQ1 fast
3.2. CSQ2 slow
3.2.1. CSQ2 deletion > catecholaminergic tachycardia
[323]
3.3. β Dystroglygan and CSQ assembly
4. Calreticulin [263]
4.1. cardiac myofibrillogenesis[324]
5. Na Ca exchanger [325]
6. IP3 [43,326]
6.1. Involvement in redox echange regulation [326]
7. Dihydropyridine receptor DHPR [251]
7.1. Voltage sensor
7.2. Linked to CSQ via junctional protein 45 [327]
7.3. Subtype 1
7.3.1. Malignant Hyperthermia
8. Ryanodine 3 gene products and splicing variants
8.1. RYR1 skeletal
8.1.1. minicore ophthalmoplegia
8.1.2. multi minicore disease
8.1.3. central core disease
8.1.4. malignant hyperthermia
8.2. RyR2 cardiac
8.2.1. arrhythmias
8.3. RyR3 cephalic muscles
8.4. Regulation by thiols [328]
8.5. Importance of glutathione [329]
8.6. Importance of Se [330]
8.7. Junctin in the structure [331]
9. Ca buffers
9.1. Parvalbumin [41]
9.2. Troponin C
9.3. Calmodulin [332]
9.4. Histidin-rich calcium binding protein
9.5. Junctate
9.6. Sarcolumenin
9.7. Mitochondria
9.8. S100 [333]
10. Role of thyroid hormones [334]
10.1. Hyperthyroidisim
10.1.1. Upregulates Na Ca exchanger
10.1.2. IP3
10.1.3. RyR
10.1.4. Myosin heavy chains
10.1.5. Gender specific action via βERB
10.1.6. Low levels of Zn [79]BMC Musculoskeletal Disorders 2007, 8:17 http://www.biomedcentral.com/1471-2474/8/17
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11. Role of Selenium and selenoproteins [279]
11.1. Regulates functional thiols of RyR
11.1.1. oxidation > open
11.1.2. reduction > closed
11.2. Selenoprotein N [335]
11.2.1. Related to rigid spine [283]
11.2.2. Minicore ophthalmoplegia [336]
11.3. Selenoprotein K
11.3.1. Cardiac antioxidant [280]
11.4. Selenoprotein W [337,338]
11.4.1. Oxidative stress [285]
12. Role of Zn
12.1. Modulation of activation and inactivation of Ca on RyR
[339]
12.2. Associated with T-tubules [340]
12.3. CSQ structure [133,135]
12.4. Ca Zn binding to calmodulin
12.5. Ca Zn and MMP [341]
12.6. HRP regulation [135]
12.7. Higher levels in red muscle [342,343]
Interactions of Se with cytokines in inflammation and
insulin resistance
1. Aging, inflammation, and muscle function
1.1. Sarcopenia [344]
1.2. increased levels of IL-6 together with reduced muscle mass
[9]
1.3. low level inflammation [345,346]
1.4. increased mortality when Se levels are low [182]
1.5. cognitive decline and IL-6 [347]
1.5.1. improved psychomotor performance after Se [348]
1.6. high IL-6 as a marker of disability [349]
1.7. IL-6 release from muscle depends on glucose and glycogen
homeostasis [184,350]
1.8. low IL-6 levels as marker of regular physical activity [351]
2. Insulin resistance
2.1. TNF induces SCOS-3 which reduces insulin receptor sub-
strate 1 [352]
2.2. Influence of IL-6 (-174) G–>C polymorphism [353]
3. Selenium
3.1. controls COX-2 levels [354]
3.2. regulation of PPAR and Zn dependence for immune regu-
lation of TNF [355]
3.3. regulation of NF-kappaB [356]
Siehe auch: controls COX-2 levels
3.4. Insulin-like activity improving GLUT1 expression [357]
3.4.1. GLUT1 and GLUT3 transport dehydroascorbic acid
[358]
3.4.2. Vitamin C and neutrophil physiology [359]
3.5. modulation of inflammation through SePS [282]
3.6. high s-Se predicts reduced levels of oxidative stress and sub-
clinical COX mediated inflammation in males [360]
3.7. Insulin resistance and increased GPX1
4. IL-6
4.1. IL-6 promoter haplotype influences ex vivo IL-6 response to
endotoxin. functional effect of 174 G–>C [243,361]
4.2. production in muscle [362] and adipocytes [363]
4.3. Ca and IL-6 [185]
4.4. relation to CRP [364]and TNF
4.5. negative correlation with DHEA and DHEA-S [365]
4.6. response to psychological stress [366]BMC Musculoskeletal Disorders 2007, 8:17 http://www.biomedcentral.com/1471-2474/8/17
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4.7. low methallothionein expression when IL-6 is elevated
[367]
4.7.1. low Zn and immune deficiency
4.8. hypoferremia in inflammation: IL-6 – hepcidin [368]and
Zip14 [244]
4.9. CC genotype and PMR relapse [369]
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